1. Home
  2. UTMD vs CCCC Comparison

UTMD vs CCCC Comparison

Compare UTMD & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utah Medical Products Inc.

UTMD

Utah Medical Products Inc.

HOLD

Current Price

$64.60

Market Cap

196.4M

Sector

Health Care

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.03

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTMD
CCCC
Founded
1978
2015
Country
US
US
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.4M
185.1M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
UTMD
CCCC
Price
$64.60
$2.03
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.25
AVG Volume (30 Days)
8.0K
874.4K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
1.92%
N/A
EPS Growth
N/A
43.07
EPS
2.68
N/A
Revenue
$40,903,000.00
$35,584,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.18
N/A
Revenue Growth
N/A
71.44
52 Week Low
$51.27
$1.09
52 Week High
$66.62
$3.64

Technical Indicators

Market Signals
Indicator
UTMD
CCCC
Relative Strength Index (RSI) 63.97 53.41
Support Level $64.22 $1.79
Resistance Level $66.62 $1.97
Average True Range (ATR) 1.57 0.14
MACD 0.12 0.02
Stochastic Oscillator 75.97 87.50

Price Performance

Historical Comparison
UTMD
CCCC

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: